Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Ocrelizumab In Adult Patients With Primary Progressive Multiple Sclerosis
Location: REDI (East Bay); Sutter East Bay Medical Foundation
Please contact: Canary Jumawan about GN41791
Principal Investigator
Joanna A. Cooper, M.D., David Eric Collins, MD
Co-Investigator(s)
Lynn Jehle, NP, Aryn Earnhardt, NP, Matthew W. Arnold, M.D., Bradley T Wrubel, MD, Antonio J Silva-Sayago, MD
Related Studies
Quantifying 2D and 3D MRI Imaging For Improving MS Diagnosis, Treatment, And Clinical Care
Investigators: Xiaowei (Sherry) Yan, PhD, MS, J.B. Jones, PhD, MBA
Using Mobile Technology and Analytics to Track Outcomes in MS Patients
Investigators: Xiaowei (Sherry) Yan, PhD, MS, J.B. Jones, PhD, MBA
Precision Medicine for Multiple Sclerosis: Making It Work (MS-SHARE)
Investigators: J.B. Jones, PhD, MBA, Xiaowei (Sherry) Yan, PhD, MS